APO Research
Talk to an analyst

APO RESEARCH · REPORT

Equine Rabies Immunoglobulin (ERIG)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Equine Rabies Immunoglobulin (ERIG) Industry Growth and Trends Forecast to 2032

2 January 202695 pages

Choose your research edition.

Industry ResearchEquine Rabies Immunoglobulin (ERIG) Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Equine Rabies Immunoglobulin (ERIG) Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Equine Rabies Immunoglobulin (ERIG) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Equine Rabies Immunoglobulin (ERIG) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Equine Rabies Immunoglobulin (ERIG) Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Equine Rabies Immunoglobulin (ERIG) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Equine Rabies Immunoglobulin (ERIG) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Equine Rabies Immunoglobulin (ERIG) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Equine Rabies Immunoglobulin (ERIG) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Equine Rabies Immunoglobulin (ERIG) include Wuhan Institute of Biological Products, Serum China, Lanzhou Institute of Biological Products, Premium Serums, Haffkine Bio-Pharmaceutical and Bharat Serums, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Equine Rabies Immunoglobulin (ERIG) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Equine Rabies Immunoglobulin (ERIG) market size, estimates, and forecasts are presented in terms of sales volume (K Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Equine Rabies Immunoglobulin (ERIG) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Equine Rabies Immunoglobulin (ERIG).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Equine Rabies Immunoglobulin (ERIG) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Equine Rabies Immunoglobulin (ERIG) Market by Company

Wuhan Institute of Biological Products

Serum China

Lanzhou Institute of Biological Products

Premium Serums

Haffkine Bio-Pharmaceutical

Bharat Serums

Equine Rabies Immunoglobulin (ERIG) Segment by Type

1500IU

1000IU

400IU

Other

Equine Rabies Immunoglobulin (ERIG) Segment by Application

Category II Exposure

Category III Exposure

Equine Rabies Immunoglobulin (ERIG) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Equine Rabies Immunoglobulin (ERIG) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Equine Rabies Immunoglobulin (ERIG) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Equine Rabies Immunoglobulin (ERIG).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Equine Rabies Immunoglobulin (ERIG) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Equine Rabies Immunoglobulin (ERIG) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1500IU Table 2. Major Company of 1000IU Table 3. Major Company of 400IU Table 4. Major Company of Other Table 5. Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2026) & (K Tons) Table 7. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Volume by Type (2021-2026) Table 8. Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2026) & (US$ Million) Table 9. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Value by Type (2021-2026) Table 10. Global Equine Rabies Immunoglobulin (ERIG) Price by Type (2021-2026) & (US$/Ton) Table 11. Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2027-2032) & (K Tons) Table 12. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Volume by Type (2027-2032) Table 13. Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2027-2032) & (US$ Million) Table 14. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Value by Type (2027-2032) Table 15. Global Equine Rabies Immunoglobulin (ERIG) Price by Type (2027-2032) & (US$/Ton) Table 16. North America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2026) & (K Tons) Table 17. North America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2026) & (K Tons) Table 19. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2026) & (K Tons) Table 21. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2026) & (K Tons) Table 23. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2026) & (K Tons) Table 25. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2026) & (US$ Million) Table 26. Equine Rabies Immunoglobulin (ERIG) Industry Trends Table 27. Equine Rabies Immunoglobulin (ERIG) Industry Drivers Table 28. Equine Rabies Immunoglobulin (ERIG) Industry Opportunities and Challenges Table 29. Equine Rabies Immunoglobulin (ERIG) Industry Restraints Table 30. Global Equine Rabies Immunoglobulin (ERIG) Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Company (2021-2026) Table 32. Global Equine Rabies Immunoglobulin (ERIG) Sales by Company (2021-2026) & (K Tons) Table 33. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Company (2021-2026) Table 34. Global Equine Rabies Immunoglobulin (ERIG) Market Price by Company (2021-2026) & (US$/Ton) Table 35. Global Equine Rabies Immunoglobulin (ERIG) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Equine Rabies Immunoglobulin (ERIG) Major Company Production Sites and Headquarters Table 37. Global Equine Rabies Immunoglobulin (ERIG) Company, Product Type & Application Table 38. Global Equine Rabies Immunoglobulin (ERIG) Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Equine Rabies Immunoglobulin (ERIG) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Equine Rabies Immunoglobulin (ERIG) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2021-2026) & (K Tons) Table 43. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Volume by Region (2021-2026) Table 44. Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2021-2026) & (US$ Million) Table 45. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Value by Region (2021-2026) Table 46. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 47. Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2027-2032) & (K Tons) Table 48. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Volume by Region (2027-2032) Table 49. Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2027-2032) & (US$ Million) Table 50. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Value by Region (2027-2032) Table 51. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 52. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2026) & (K Tons) Table 54. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Volume by Application (2021-2026) Table 55. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2026) & (US$ Million) Table 56. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Value by Application (2021-2026) Table 57. Global Equine Rabies Immunoglobulin (ERIG) Price by Application (2021-2026) & (US$/Ton) Table 58. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2027-2032) & (K Tons) Table 59. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Volume by Application (2027-2032) Table 60. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2027-2032) & (US$ Million) Table 61. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Value by Application (2027-2032) Table 62. Global Equine Rabies Immunoglobulin (ERIG) Price by Application (2027-2032) & (US$/Ton) Table 63. North America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2026) & (K Tons) Table 64. North America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2026) & (K Tons) Table 66. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2026) & (K Tons) Table 68. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2026) & (K Tons) Table 70. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2026) & (K Tons) Table 72. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2026) & (US$ Million) Table 73. Wuhan Institute of Biological Products Company Information Table 74. Wuhan Institute of Biological Products Business Overview Table 75. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Portfolio Table 77. Wuhan Institute of Biological Products Recent Development Table 78. Serum China Company Information Table 79. Serum China Business Overview Table 80. Serum China Equine Rabies Immunoglobulin (ERIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Serum China Equine Rabies Immunoglobulin (ERIG) Product Portfolio Table 82. Serum China Recent Development Table 83. Lanzhou Institute of Biological Products Company Information Table 84. Lanzhou Institute of Biological Products Business Overview Table 85. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Portfolio Table 87. Lanzhou Institute of Biological Products Recent Development Table 88. Premium Serums Company Information Table 89. Premium Serums Business Overview Table 90. Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Premium Serums Equine Rabies Immunoglobulin (ERIG) Product Portfolio Table 92. Premium Serums Recent Development Table 93. Haffkine Bio-Pharmaceutical Company Information Table 94. Haffkine Bio-Pharmaceutical Business Overview Table 95. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product Portfolio Table 97. Haffkine Bio-Pharmaceutical Recent Development Table 98. Bharat Serums Company Information Table 99. Bharat Serums Business Overview Table 100. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product Portfolio Table 102. Bharat Serums Recent Development Table 103. North America Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 104. North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021-2026) & (K Tons) Table 105. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2021-2026) Table 106. North America Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Country (2027-2032) & (K Tons) Table 107. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share Forecast by Country (2027-2032) Table 108. North America Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Equine Rabies Immunoglobulin (ERIG) Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Equine Rabies Immunoglobulin (ERIG) Market Share by Country (2021-2026) Table 111. North America Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Equine Rabies Immunoglobulin (ERIG) Market Share Forecast by Country (2027-2032) Table 113. Europe Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 114. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021-2026) & (K Tons) Table 115. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2021-2026) Table 116. Europe Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Country (2027-2032) & (K Tons) Table 117. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share Forecast by Country (2027-2032) Table 118. Europe Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Equine Rabies Immunoglobulin (ERIG) Market Share by Country (2021-2026) Table 121. Europe Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Equine Rabies Immunoglobulin (ERIG) Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021-2026) & (K Tons) Table 125. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2021-2026) Table 126. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Country (2027-2032) & (K Tons) Table 127. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Market Share by Country (2021-2026) Table 131. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Market Share Forecast by Country (2027-2032) Table 133. Latin America Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 134. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021-2026) & (K Tons) Table 135. Latin America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2021-2026) Table 136. Latin America Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Country (2027-2032) & (K Tons) Table 137. Latin America Equine Rabies Immunoglobulin (ERIG) Sales Market Share Forecast by Country (2027-2032) Table 138. Latin America Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Equine Rabies Immunoglobulin (ERIG) Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Equine Rabies Immunoglobulin (ERIG) Market Share by Country (2021-2026) Table 141. Latin America Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Equine Rabies Immunoglobulin (ERIG) Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021-2026) & (K Tons) Table 145. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2021-2026) Table 146. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Country (2027-2032) & (K Tons) Table 147. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Share by Country (2021-2026) Table 151. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Share Forecast by Country (2027-2032) Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Equine Rabies Immunoglobulin (ERIG) Distributors List Table 156. Equine Rabies Immunoglobulin (ERIG) Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Equine Rabies Immunoglobulin (ERIG) Image Figure 2. Global Equine Rabies Immunoglobulin (ERIG) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Equine Rabies Immunoglobulin (ERIG) Market Size (2021-2032) & (US$ Million) Figure 4. Global Equine Rabies Immunoglobulin (ERIG) Sales (2021-2032) & (K Tons) Figure 5. 1500IU Image Figure 6. Global 1500IU Sales YoY Growth (2021-2032) & (K Tons) Figure 7. 1000IU Image Figure 8. Global 1000IU Sales YoY Growth (2021-2032) & (K Tons) Figure 9. 400IU Image Figure 10. Global 400IU Sales YoY Growth (2021-2032) & (K Tons) Figure 11. Other Image Figure 12. Global Other Sales YoY Growth (2021-2032) & (K Tons) Figure 13. Global Equine Rabies Immunoglobulin (ERIG) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Equine Rabies Immunoglobulin (ERIG) Market Share by Type 2025 VS 2032 Figure 15. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Volume by Type in 2025 Figure 16. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Value by Type in 2025 Figure 17. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Volume by Type in 2025 Figure 18. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Value by Type in 2025 Figure 21. Latin America Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Equine Rabies Immunoglobulin (ERIG) Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Category II Exposure Image Figure 28. Global Category II Exposure Sales YoY Growth (2021-2032) & (K Tons) Figure 29. Category III Exposure Image Figure 30. Global Category III Exposure Sales YoY Growth (2021-2032) & (K Tons) Figure 31. Global Equine Rabies Immunoglobulin (ERIG) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Equine Rabies Immunoglobulin (ERIG) Market Share by Application 2025 VS 2032 Figure 33. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Volume by Application in 2025 Figure 34. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Value by Application in 2025 Figure 35. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Volume by Application in 2025 Figure 36. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Value by Application in 2025 Figure 39. Latin America Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share in Value by Application in 2025 Figure 43. North America Equine Rabies Immunoglobulin (ERIG) Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 44. North America Equine Rabies Immunoglobulin (ERIG) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Equine Rabies Immunoglobulin (ERIG) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Equine Rabies Immunoglobulin (ERIG) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 48. Europe Equine Rabies Immunoglobulin (ERIG) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Equine Rabies Immunoglobulin (ERIG) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 52. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 56. Latin America Equine Rabies Immunoglobulin (ERIG) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Equine Rabies Immunoglobulin (ERIG) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Equine Rabies Immunoglobulin (ERIG) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 60. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Equine Rabies Immunoglobulin (ERIG) Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Equine Rabies Immunoglobulin (ERIG) Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 1500IU
  • 1000IU
  • 400IU
  • Other
Applications
  • Category II Exposure
  • Category III Exposure
Companies covered
  • Wuhan Institute of Biological Products
  • Serum China
  • Lanzhou Institute of Biological Products
  • Premium Serums
  • Haffkine Bio-Pharmaceutical
  • Bharat Serums

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Equine Rabies Immunoglobulin (ERIG) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Equine Rabies Immunoglobulin (ERIG) Market by Type
  6. 1.3.1 1500IU
  7. 1.3.2 1000IU
  8. 1.3.3 400IU
  9. 1.3.4 Other
  10. 1.4 Global Equine Rabies Immunoglobulin (ERIG) Market Size by Type
  11. 1.4.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Equine Rabies Immunoglobulin (ERIG) Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Equine Rabies Immunoglobulin (ERIG) Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Equine Rabies Immunoglobulin (ERIG) Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Equine Rabies Immunoglobulin (ERIG) Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Equine Rabies Immunoglobulin (ERIG) Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Equine Rabies Immunoglobulin (ERIG) Industry Trends
  2. 2.2 Equine Rabies Immunoglobulin (ERIG) Industry Drivers
  3. 2.3 Equine Rabies Immunoglobulin (ERIG) Industry Opportunities and Challenges
  4. 2.4 Equine Rabies Immunoglobulin (ERIG) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2026)
  2. 3.2 Global Top Players by Equine Rabies Immunoglobulin (ERIG) Sales (2021-2026)
  3. 3.3 Global Top Players by Equine Rabies Immunoglobulin (ERIG) Price (2021-2026)
  4. 3.4 Global Equine Rabies Immunoglobulin (ERIG) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Equine Rabies Immunoglobulin (ERIG) Major Company Production Sites & Headquarters
  6. 3.6 Global Equine Rabies Immunoglobulin (ERIG) Company, Product Type & Application
  7. 3.7 Global Equine Rabies Immunoglobulin (ERIG) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Equine Rabies Immunoglobulin (ERIG) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Equine Rabies Immunoglobulin (ERIG) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Equine Rabies Immunoglobulin (ERIG) Tier 1, Tier 2, and Tier 3
4 Equine Rabies Immunoglobulin (ERIG) Regional Status and Outlook
  1. 4.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Equine Rabies Immunoglobulin (ERIG) Historic Market Size by Region
  3. 4.2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Equine Rabies Immunoglobulin (ERIG) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Equine Rabies Immunoglobulin (ERIG) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Equine Rabies Immunoglobulin (ERIG) Forecasted Market Size by Region
  7. 4.3.1 Global Equine Rabies Immunoglobulin (ERIG) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Equine Rabies Immunoglobulin (ERIG) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Equine Rabies Immunoglobulin (ERIG) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Equine Rabies Immunoglobulin (ERIG) by Application
  1. 5.1 Equine Rabies Immunoglobulin (ERIG) Market by Application
  2. 5.1.1 Category II Exposure
  3. 5.1.2 Category III Exposure
  4. 5.2 Global Equine Rabies Immunoglobulin (ERIG) Market Size by Application
  5. 5.2.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Equine Rabies Immunoglobulin (ERIG) Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Equine Rabies Immunoglobulin (ERIG) Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Equine Rabies Immunoglobulin (ERIG) Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Equine Rabies Immunoglobulin (ERIG) Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Equine Rabies Immunoglobulin (ERIG) Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Wuhan Institute of Biological Products
  2. 6.1.1 Wuhan Institute of Biological Products Company Information
  3. 6.1.2 Wuhan Institute of Biological Products Business Overview
  4. 6.1.3 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Portfolio
  6. 6.1.5 Wuhan Institute of Biological Products Recent Developments
  7. 6.2 Serum China
  8. 6.2.1 Serum China Company Information
  9. 6.2.2 Serum China Business Overview
  10. 6.2.3 Serum China Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Serum China Equine Rabies Immunoglobulin (ERIG) Product Portfolio
  12. 6.2.5 Serum China Recent Developments
  13. 6.3 Lanzhou Institute of Biological Products
  14. 6.3.1 Lanzhou Institute of Biological Products Company Information
  15. 6.3.2 Lanzhou Institute of Biological Products Business Overview
  16. 6.3.3 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Portfolio
  18. 6.3.5 Lanzhou Institute of Biological Products Recent Developments
  19. 6.4 Premium Serums
  20. 6.4.1 Premium Serums Company Information
  21. 6.4.2 Premium Serums Business Overview
  22. 6.4.3 Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Premium Serums Equine Rabies Immunoglobulin (ERIG) Product Portfolio
  24. 6.4.5 Premium Serums Recent Developments
  25. 6.5 Haffkine Bio-Pharmaceutical
  26. 6.5.1 Haffkine Bio-Pharmaceutical Company Information
  27. 6.5.2 Haffkine Bio-Pharmaceutical Business Overview
  28. 6.5.3 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product Portfolio
  30. 6.5.5 Haffkine Bio-Pharmaceutical Recent Developments
  31. 6.6 Bharat Serums
  32. 6.6.1 Bharat Serums Company Information
  33. 6.6.2 Bharat Serums Business Overview
  34. 6.6.3 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product Portfolio
  36. 6.6.5 Bharat Serums Recent Developments
7 North America by Country
  1. 7.1 North America Equine Rabies Immunoglobulin (ERIG) Sales by Country
  2. 7.1.1 North America Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021-2026)
  4. 7.1.3 North America Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Equine Rabies Immunoglobulin (ERIG) Market Size by Country
  6. 7.2.1 North America Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Equine Rabies Immunoglobulin (ERIG) Market Size by Country (2021-2026)
  8. 7.2.3 North America Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country
  2. 8.1.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021-2026)
  4. 8.1.3 Europe Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Country
  6. 8.2.1 Europe Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Country
  2. 9.1.1 Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Market Size by Country
  6. 9.2.1 Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Equine Rabies Immunoglobulin (ERIG) Sales by Country
  2. 10.1.1 South America Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021-2026)
  4. 10.1.3 South America Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Equine Rabies Immunoglobulin (ERIG) Market Size by Country
  6. 10.2.1 South America Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Equine Rabies Immunoglobulin (ERIG) Market Size by Country (2021-2026)
  8. 10.2.3 South America Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country
  2. 11.1.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Size by Country
  6. 11.2.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Equine Rabies Immunoglobulin (ERIG) Value Chain Analysis
  2. 12.1.1 Equine Rabies Immunoglobulin (ERIG) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Equine Rabies Immunoglobulin (ERIG) Production Mode & Process
  7. 12.2 Equine Rabies Immunoglobulin (ERIG) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Equine Rabies Immunoglobulin (ERIG) Distributors
  10. 12.2.3 Equine Rabies Immunoglobulin (ERIG) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst